Evidence map›Paper›PMID 36304838›Full record

ArticleJournal of applied glycoscience2022

Eri Kokubo, Hirofumi Sonoki, Kenta Aizawa, Hiroki Takagi, Masayasu Takada, Ayako Ito, Yuki Nakazato, Yasuhiro Takeda, Kazuhiro Miyaji

Open access · diamondAbstract read
In one paragraph

Article in Journal of applied glycoscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Eri Kokubo1 Health Care & Nutritional Science Institute, R&D Division, Morinaga Milk Industry Co., Ltd.
Hirofumi Sonoki1 Health Care & Nutritional Science Institute, R&D Division, Morinaga Milk Industry Co., Ltd.
Kenta Aizawa2 Research Institute, Nihon Shokuhin Kako Co., Ltd.
Hiroki Takagi2 Research Institute, Nihon Shokuhin Kako Co., Ltd.
Masayasu Takada2 Research Institute, Nihon Shokuhin Kako Co., Ltd.
Ayako Ito1 Health Care & Nutritional Science Institute, R&D Division, Morinaga Milk Industry Co., Ltd.
Yuki Nakazato1 Health Care & Nutritional Science Institute, R&D Division, Morinaga Milk Industry Co., Ltd.
Yasuhiro Takeda1 Health Care & Nutritional Science Institute, R&D Division, Morinaga Milk Industry Co., Ltd.
Kazuhiro Miyaji1 Health Care & Nutritional Science Institute, R&D Division, Morinaga Milk Industry Co., Ltd.
Megmilk Snow Brand (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Slowly digestible carbohydrates are needed for nutritional support in diabetic patients with malnutrition. They are a good source of energy and have the advantage that their consumption produces a low postprandial peak in blood glucose levels because they are slowly and completely digested in the small intestine. A high-amount isomaltomegalosaccharide containing carbohydrate (H-IMS), made from starch by dextrin dextranase, is a mixture of glucose polymers which has a continuous linear structure of α-1,6-glucosidic bonds and a small number of α-1,4-glucosidic bonds at the reducing ends. It has a broad degree of polymerization (DP) distribution with glucans of DP 10-30 as the major component. In our previous study, H-IMS has been shown to exhibit slow digestibility

Indexed as

breath hydrogendigestibilityfecal excretionisomaltomegalosaccharideslowly digestible carbohydrateα-1,6-glucan

Identifiers

PMID36304838
PMCPMC9534827
OpenAlexW4224272120

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.